Role of liver sinusoidal endothelial cells in liver diseases

J Gracia-Sancho, E Caparrós… - Nature reviews …, 2021 - nature.com
Liver sinusoidal endothelial cells (LSECs) form the wall of the hepatic sinusoids. Unlike
other capillaries, they lack an organized basement membrane and have cytoplasm that is …

FDA-approved oligonucleotide therapies in 2017

CA Stein, D Castanotto - Molecular Therapy, 2017 - cell.com
Oligonucleotides (oligos) have been under clinical development for approximately the past
30 years, beginning with antisense oligonucleotides (ASOs) and apatmers and followed …

Liver sinusoidal endothelial cells: Physiology and role in liver diseases

J Poisson, S Lemoinne, C Boulanger, F Durand… - Journal of …, 2017 - Elsevier
Liver sinusoidal endothelial cells (LSECs) are highly specialized endothelial cells
representing the interface between blood cells on the one side and hepatocytes and hepatic …

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for …

S Corbacioglu, E Carreras, M Ansari… - Bone marrow …, 2018 - nature.com
The advances in hematopoietic cell transplantation (HCT) over the last decade have led to a
transplant-related mortality below 15%. Hepatic sinusoidal obstruction syndrome/veno …

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

Y Yu, Y Mao, C Chen, J Chen, J Chen, W Cong… - Hepatology …, 2017 - Springer
Drug-induced liver injury (DILI) is an important clinical problem, which has received more
attention in recent decades. It can be induced by small chemical molecules, biological …

[HTML][HTML] Risk factors for development of and progression of hepatic veno-occlusive disease/sinusoidal obstruction syndrome

S Corbacioglu, EJ Jabbour, M Mohty - Biology of Blood and Marrow …, 2019 - Elsevier
Veno-occlusive disease, also known as sinusoidal obstruction syndrome (VOD/SOS), is a
potentially life-threatening complication of allogeneic or autologous hematopoietic stem cell …

Secondary immunodeficiency in hematological malignancies: focus on multiple myeloma and chronic lymphocytic leukemia

A Allegra, A Tonacci, C Musolino, G Pioggia… - Frontiers in …, 2021 - frontiersin.org
Secondary immunodeficiency is reported in most patients with hematological malignancies
such as chronic lymphocytic leukemia and multiple myeloma. The aim of our review was to …

[HTML][HTML] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

J Lv, L Guo, JJ Liu, HP Zhao, J Zhang… - World journal of …, 2019 - ncbi.nlm.nih.gov
The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …

Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems

VK Singh, TM Seed - Expert opinion on pharmacotherapy, 2020 - Taylor & Francis
Introduction: There is a limited array of currently available medicinals that are useful for
either the prevention, mitigation or treatment of bodily injuries arising from ionizing radiation …

[HTML][HTML] Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes

XQ Yang, J Ye, X Li, Q Li, YH Song - World Journal of …, 2019 - ncbi.nlm.nih.gov
Hepatic sinusoidal obstruction syndrome (HSOS) can be caused by the intake of
pyrrolizidine alkaloids (PAs). To date, PAs-induced HSOS has not been extensively studied …